Justin Taylor, Assistant Professor at the UM Sylvester Comprehensive Cancer Center, shared a post on X:
“Wow, big news today! Was not expecting this and leaves a big unmet need still for MDS.
Roche, AbbVie say trial of Venclexta in patients with myelodysplastic syndromes falls short.”
More posts featuring Justin Taylor on OncoDaily.